Kairali Exports Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Kairali Exports Pharmaceutical Export Portfolio Dataset — 3 Products, $104.7K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Kairali Exports — Pharmaceutical Exporter Profile (2026) | 3 Products, $104.7K Trade | TransData Nexus

Product Portfolio — Top 3 by Export Value

Kairali Exports exports 3 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Taila	Ayurvedic & Herbal Products	$64.1K	179	0.8%	14
2	Kwatha	Ayurvedic & Herbal Products	$26.2K	105	4.9%	8
3	Arishta	Ayurvedic & Herbal Products	$14.5K	73	1.0%	11

Kairali Exports exports 3 pharmaceutical products across 1 therapeutic categories with a total export value of $104.7K. The top category is Ayurvedic & Herbal Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Kairali Exports — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

Kairali Exports is an Indian pharmaceutical exporter specializing in finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established in 2000, the company is headquartered in Thiruvananthapuram, Kerala. It operates as a proprietary firm, classified as a micro enterprise under the MSME Act for the financial year 2023-24. The company's Corporate Identification Number (CIN) is UDYAM-KL-12-0015376. Specific details regarding revenue, employee count, and website are not publicly disclosed.

2Manufacturing Facilities

Kairali Exports operates manufacturing facilities in Thiruvananthapuram, Kerala. The company specializes in the production of Ayurvedic and herbal pharmaceutical formulations, focusing on finished products such as tablets, capsules, syrups, and injections. Specific details regarding plant capacities and certifications are not publicly available.

3Key Leadership

The leadership team of Kairali Exports includes:

Mr. Ayurvastra: Proprietor

Mr. Kokki Kumar: CEO

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Kairali Exports Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Kairali Exports has a presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has engaged in export activities to these regions, with shipments recorded to countries such as the United States, Italy, and Poland. However, specific details regarding regulatory filings, approvals, and market access status in these countries are not publicly disclosed.

2Emerging Markets

Kairali Exports has expanded its reach to emerging markets in Africa, Latin America, and Southeast Asia. The company has engaged in export activities to countries such as Ghana, Senegal, Ivory Coast, Guinea Bissau, and Nigeria. Specific details regarding WHO prequalification or other certifications enabling access to these markets are not publicly available.

3Geographic Strategy

Kairali Exports demonstrates a diversified geographic strategy, exporting to a range of countries across the Middle East, Europe, and Africa. This diversification helps mitigate concentration risk and indicates a strategic direction focused on expanding its global footprint. However, specific strategic initiatives or future outlooks are not publicly disclosed.

Kairali Exports — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Kairali Exports' FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. The company's export activities to the United States suggest some level of compliance with FDA regulations, but detailed information is not disclosed.

2WHO & EU GMP

Specific details regarding Kairali Exports' WHO prequalification, EU Good Manufacturing Practice (GMP) certificates, or European Directorate for the Quality of Medicines & HealthCare (EDQM) status are not publicly available. The company's export activities to various countries indicate adherence to international quality standards, but detailed certifications are not disclosed.

3CDSCO & Indian Regulatory

Specific details regarding Kairali Exports' Central Drugs Standard Control Organisation (CDSCO) manufacturing licenses, state drug controller approvals, or export No Objection Certificates (NOCs) are not publicly available. The company's operations in India suggest compliance with national regulatory requirements, but detailed information is not disclosed.

Kairali Exports — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Kairali Exports operates in the Ayurvedic and herbal pharmaceutical sector, competing with other Indian exporters in this niche market. While specific competitors and market share comparisons are not publicly disclosed, the company's focus on finished pharmaceutical formulations positions it within a competitive landscape that includes both domestic and international players.

2Key Differentiators

Kairali Exports' specialization in Ayurvedic and herbal pharmaceutical formulations, particularly finished products such as tablets, capsules, syrups, and injections, distinguishes it in the market. The company's diversified export destinations across the Middle East, Europe, and Africa further enhance its competitive advantage.

3Strategic Position

Kairali Exports' current strategic direction appears to focus on expanding its global footprint through diversified export activities. The company's engagement in both regulated and emerging markets indicates a balanced approach to growth. However, specific strategic initiatives or future outlooks are not publicly disclosed.

Buyer Due Diligence Brief — Evaluating Kairali Exports as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Kairali Exports has a track record of exporting a range of pharmaceutical products, including Ayurvedic and herbal formulations, to various international markets. The company's export volume and consistency suggest reliability as a supplier. However, specific indicators of reliability, such as customer feedback or quality certifications, are not publicly available.

2Certifications to Verify

Importers should verify the following certifications when considering Kairali Exports as a supplier:

FDA Registration: To ensure compliance with U.S. regulations. Verification can be done through the FDA's official website.

WHO-GMP Certification: To confirm adherence to international manufacturing standards. Verification can be done through the World Health Organization's official website.

EU GMP Certification: To ensure compliance with European manufacturing standards. Verification can be done through the European Medicines Agency's official website.

Frequently Asked Questions — Kairali Exports

How many pharmaceutical products does Kairali Exports export from India?

Kairali Exports exports 3 pharmaceutical products across 1 therapeutic categories. The top exports are Taila ($64.1K), Kwatha ($26.2K), Arishta ($14.5K). Total export value is $104.7K.

What is Kairali Exports's total pharmaceutical export value?

Kairali Exports's total pharmaceutical export value is $104.7K, based on 357 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Kairali Exports cover?

Kairali Exports exports across 1 therapeutic categories. The largest are Ayurvedic & Herbal Products (100.0%, 3 products).

Get Full Kairali Exports Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.

Kairali Exports

Kairali Exports — Export Portfolio & Destination Treemap

Who is Kairali Exports? — Company Overview & Market Position

What Does Kairali Exports Export? — Product Portfolio Analysis

Top Products by Export Value

Kairali Exports Therapeutic Categories — 1 Specializations